Panbela Therapeutics Inc.
(PBLA)
undefined
undefined%
At close: undefined
0.35
11.18%
Pre-market Nov 29, 2024, 09:30 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Net Income | -25.26M | -34.93M | -10.13M | -4.77M | -6.20M | -5.91M | -10.37M | -5.11M | -4.93M | -107.04K | -212.02K | 247.38K | -138.31K |
Depreciation & Amortization | - | - | - | 114.00K | 2.07M | - | - | 28.00K | 28.00K | 9.58K | 8.79K | 5.64K | 3.10K |
Stock-Based Compensation | 823.00K | 1.09M | 1.29M | 1.21M | 1.09M | 1.28M | 1.73M | 902.00K | 976.00K | 196.00 | 600.00 | 600.00 | 600.00 |
Other Working Capital | -7.71M | -1.69M | 1.51M | 559.00K | -113.00K | 134.00K | 257.00K | 620.00K | -655.00K | -17.15K | 6.00K | 2.56K | 4.40K |
Other Non-Cash Items | -162.00K | 18.01M | 605.00K | -103.00K | 2.18M | 1.75M | 5.30M | 12.00K | 1.00M | 33.98K | 114.38K | 116.16K | 169.90K |
Deferred Income Tax | - | - | - | -114.00K | -2.07M | - | - | - | -1.00M | - | - | -833 | - |
Change in Working Capital | -647.00K | 559.00K | 2.14M | -188.00K | 188.00K | 494.00K | -62.00K | 1.77M | 26.00K | 52.04K | 52.86K | -331.83K | -108.33K |
Operating Cash Flow | -25.25M | -15.28M | -6.70M | -3.85M | -2.74M | -2.39M | -3.40M | -2.40M | -3.90M | -11.45K | -35.39K | 37.11K | -73.04K |
Capital Expenditures | - | -660.00K | - | - | - | - | - | - | - | - | -5.12K | - | -9.53K |
Acquisitions | - | 4.00K | - | - | - | - | - | - | - | - | - | - | - |
Purchase of Investments | - | - | - | - | - | - | - | - | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - | - | - | - | 500.00K | - | - | 19.12K | - |
Other Investing Acitivies | 400.00K | -656.00K | -540.00K | - | - | - | - | - | 500.00 | 124.72K | -5.12K | 833.00 | - |
Investing Cash Flow | 400.00K | -656.00K | -540.00K | - | - | - | - | - | 500.00K | 124.72K | -5.12K | 19.12K | -9.53K |
Debt Repayment | -1.65M | - | - | - | 624.00K | 1.31M | 3.06M | - | - | 2.39M | - | 6.85K | 8.90K |
Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Financial Acitivies | 4.75M | 5.00K | 1.04M | -637.00K | - | - | 47.00K | 42.00K | 1.16M | -2.40M | -11.61K | - | - |
Financial Cash Flow | 26.14M | 5.35M | 10.10M | 10.44M | 3.78M | 3.64M | 3.11K | 1.92K | 2.67K | -8.32K | -11.61K | 6.85K | 8.90K |
Net Cash Flow | 1.29M | -10.58M | 2.85M | 6.57M | 1.04M | 1.25M | -286.00K | -487.00K | -729.00K | 104.95K | -52.12K | 63.09K | -73.67K |
Free Cash Flow | -25.25M | -15.94M | -6.70M | -3.85M | -2.74M | -2.39M | -3.40M | -2.40M | -3.90M | -11.45K | -40.51K | 37.11K | -82.57K |